Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Anika Therapeutics
(NQ:
ANIK
)
25.60
+0.06 (+0.23%)
Streaming Delayed Price
Updated: 3:45 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Anika Therapeutics
< Previous
1
2
3
Next >
Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
July 20, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting
July 12, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone
May 30, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Recap: Anika Therapeutics Q1 Earnings
May 09, 2023
Via
Benzinga
Anika Therapeutics Earnings Preview
March 03, 2023
Via
Benzinga
New FDA 510(k) Clearance Expands Anika's Sports Medicine Soft Tissue Portfolio
May 20, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
March 11, 2022
During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest...
Via
Benzinga
Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023
April 19, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Enters Into Cooperation Agreement with Caligan Partners
April 13, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference
April 12, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Continues to Expand Addressable Market for Tactoset® Injectable Bone Substitute with Additional 510(k) Clearance from FDA
April 03, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Files Preliminary Proxy Statement
March 27, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
March 15, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Highlights Products in High Growth Segments of Joint Preservation during the 2023 AAOS Annual Meeting
March 08, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
March 07, 2023
Via
Benzinga
Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
February 28, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue Fourth Quarter and Year-End 2022 Financial Results on Monday, March 6, 2023
February 21, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Issues Statement
February 21, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Announces First Surgeries Performed Using the New RevoMotion™ Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States
February 13, 2023
From
Anika Therapeutics Inc.
Via
GlobeNewswire
7 Stocks to Buy Before the Market Starts to Soar in 2023
November 10, 2022
With the market falling into a bit of disarray, astute investors can leverage this moment to dive into compelling stocks to buy.
Via
InvestorPlace
Anika Therapeutics Cingal Tops Steroid For Osteoarthritis Pain Relief
November 01, 2022
Via
Benzinga
Anika’s Cingal® Successfully Achieves Primary Endpoint in Third Phase III Study
November 01, 2022
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022
October 25, 2022
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Anika Therapeutics: Q2 Earnings Insights
August 03, 2022
Anika Therapeutics (NASDAQ:ANIK) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Anika Receives the ACE Award for Cutting-Edge Innovation for Tactoset® Injectable Bone Substitute from the American Orthopedic Society for Sports Medicine
July 27, 2022
From
Anika Therapeutics Inc.
Via
GlobeNewswire
Sidoti's Summer Small Cap Virtual Conference
June 14, 2022
NEW YORK, NY / ACCESSWIRE / June 14, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day Summer Small Cap Virtual Conference taking place Wednesday and...
From
Sidoti & Company, LLC
Via
AccessWire
Stocks That Hit 52-Week Lows On Wednesday
March 09, 2022
During Wednesday's session, 35 companies made new 52-week lows. 52-Week High And Low Highlights: The company with the largest market cap to set a new 52-week low was...
Via
Benzinga
Anika Therapeutics: Q4 Earnings Insights
March 08, 2022
Anika Therapeutics (NASDAQ:ANIK) reported its Q4 earnings results on Tuesday, March 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
March 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...
Via
Benzinga
Earnings Scheduled For March 8, 2022
March 08, 2022
Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.